UK markets closed

Scinai Immunotherapeutics Ltd. (SCNI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5900-0.1500 (-4.01%)
As of 12:22PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-6,500
-6,500
-5,796
-8,206
-1,385
-
Depreciation & amortisation
514
514
562
471
757.5687
-
Stock-based compensation
1,139
1,139
1,602
2,757
2,946
-
Change in working capital
-796
-796
271
704
-28,840
-
Accounts payable
-150
-150
-175
3
-4,725
-
Other working capital
-10,019
-10,019
-8,101
-7,565
-24,466
-
Other non-cash items
401
401
-3,904
-3,152
3,974
-
Net cash provided by operating activities
-9,382
-9,382
-7,265
-7,426
-22,559
-
Cash flows from investing activities
Investments in property, plant and equipment
-637
-637
-836
-139
-1,907
-
Sales/maturities of investments
-
-
-
-
-
0
Other investing activities
-
-
-
9.3328
11.5066
66.4202
Net cash used for investing activities
-637
-637
-836
-139
-1,846
-
Cash flows from financing activities
Debt repayment
-
-
-
-392.6226
-385.6261
-167.7833
Common stock issued
139
139
932
21,430
0
-
Net cash used provided by (used for) financing activities
1,086
1,086
6,776
21,430
4,266
-
Net change in cash
-9,205
-9,205
-3,302
14,440
-19,607
-
Cash at beginning of period
14,215
14,215
17,517
3,077
22,536
-
Cash at end of period
5,010
5,010
14,215
17,517
2,930
-
Free cash flow
Operating cash flow
-9,382
-9,382
-7,265
-7,426
-22,559
-
Capital expenditure
-637
-637
-836
-139
-1,907
-
Free cash flow
-10,019
-10,019
-8,101
-7,565
-24,466
-